Efficacy and Safety of Gynostemma Pentaphyllum(Dungkulcha) Extract on Alleviation of Chronic Stress-induced Strain
- Conditions
- Chronic Stress-Induced Strain
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: Gynostemma Pentaphyllum(Dungkulcha) Extract(400mg/day)
- Registration Number
- NCT03277833
- Lead Sponsor
- Chonbuk National University Hospital
- Brief Summary
The investigators performed a 8-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Gynostemma Pentaphyllum(Dungkulcha) on alleviation of chronic stress-induced strain. The investigators measured decrement of body fat parameters, State\&Trait version of STAI, Beck Anxiety Inventory(BAI), Hamilton Anxiety Inventory(HAM-A), and monitored their blood pressure.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 72
• Age 20-65 years with chronic stress( S-STAI score 40~60)
- excessive physically chronic fatigue
- Subjects taking antidepressants, anxiolytics, hypnotics within the last 2 months prior to the study
- Cardiovascular disease
- Allergic or hypersensitive to any of the ingredients in the test products
- History of reaction to any of the test products or of gastrointestinal diseases such as Crohn's disease or gastrointestinal surgery
- Participation in any other clinical trials within past 2 months
- Renal disease
- Abnormal hepatic function
- Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
- History of alcohol or substance abuse
- Pregnancy or lacting women etc.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo Placebo Placebo Gynostemma Pentaphyllum(Dungkulcha) Extract Gynostemma Pentaphyllum(Dungkulcha) Extract(400mg/day) Gynostemma Pentaphyllum(Dungkulcha) Extract (400mg/d)
- Primary Outcome Measures
Name Time Method Change in score of State&Trait version of STAI Baseline and 8 weeks Score of State\&Trait version of STAI was measured in study screening and visit 3(8 week).
- Secondary Outcome Measures
Name Time Method Change of Blood Norepinephrine Level Baseline and 8 week Blood norepinephrine level was measured in study visit 1(0 week) and visit 3(8 week).
Change of Blood Cortisol Level Baseline and 8 week Blood cortisol level was measured in study visit 1(0 week) and visit 3(8 week).
Change in score of Beck Anxiety Inventory Baseline and 8 week Score of Beck Anxiety Inventory was measured in study visit 1(0 week) and visit 3(8 week).